MicrovascularVitals:WeAreUsingWearablestheWrongWay

Abstract

Wearables are becoming one of the most important interfaces between humans, health data, and AI agents. However, the dominant approach to wearable biosensing may be too narrow.

Most wearable systems still use advanced sensors and continuous monitoring to reconstruct traditional macro-vitals such as heart rate, oxygen saturation, respiratory rate and increasingly blood pressure. These measurements are useful and clinically important, but they represent an older physiological framework built around what was practical to measure at the time.

The human body is far more dynamic than this macro-vital layer alone can describe. Many everyday physiological states — hydration, tissue perfusion, recovery, stress load, infection-related physiological drift, muscle recovery, gut-related metabolic slowdown, and male sexual vascular function — may begin as microvascular and autonomic changes before they appear clearly in traditional vital signs.

Here I argue that the future of wearables is not simply better heart rate, better SpO₂, or cuffless blood pressure. The bigger opportunity is to use wearable PPG, rPPG, and related optical biosignals to create a new layer of Microvascular Vitals: condition-linked, baseline-personalized, continuous physiological indicators that describe what is happening in the body earlier, faster, and more meaningfully than macro-vitals alone.

In the age of AI and health agents, this may become one of the most important missing layers in human health monitoring.

1. The problem: we are using new technology with an old physiological framework

Heart rate, blood pressure, respiratory rate, temperature, and oxygen saturation became the core language of human physiology because they were practical, measurable, and clinically useful.

They were developed and adopted in an era where the body was measured occasionally. A nurse checked the blood pressure. A doctor checked the pulse. A thermometer measured temperature. A pulse oximeter measured oxygen saturation. A monitor displayed basic vital signs. This was the best available approach for that time.

These vitals changed medicine. They are still essential. In emergency medicine, intensive care, surgery, anaesthesia, primary care, and remote monitoring, macro-vitals remain foundational.

But they are not the complete picture of physiology. They are broad, whole-body signals. They are downstream measurements. They often show change only when the body has already moved far enough for the compensation to become visible.

The problem is that technology has evolved, but our physiological framework has not evolved at the same speed. We now have sensors sitting on the body continuously. We have optical signals, motion signals, temperature trends, sleep data, activity context, and AI models. We are collecting data during sleep, training, stress, meals, illness, travel, hydration, and recovery.

But much of the wearable industry is still asking the old question:

Can we use this new technology to measure the old vitals. Can we estimate blood pressure? Can we improve heart rate accuracy? Can we measure SpO₂ from the wrist? Can we convert wearable signals into hospital-style vital signs?

These are useful questions. But they may not be the most important question.

The better question is:

What new physiological biomarkers can we build from wearable microvascular data directly?

2. Macro-vitals are useful, but they are late and non-specific

Traditional vitals are simple. That is their strength. But that is also their limitation. Heart rate is non-specific. It can increase because of dehydration, fever, anxiety, pain, caffeine, exercise, poor sleep, medication, early infection, bleeding, or shock.

Blood pressure is also non-specific. It can remain normal while the body is compensating, and it can fall late in many physiological processes. SpO₂ is important, but a normal oxygen saturation does not mean tissue perfusion is optimal. Temperature is useful, but fever is often a late or incomplete signal of inflammation or infection.

This is the problem with macro-vitals. They are easy to measure, but they are not always early. They are objective, but not always specific. They are clinically powerful, but often too broad for everyday physiological interpretation.

The body is designed to protect macro-vitals. It works hard to maintain blood pressure, oxygen delivery, core temperature, and circulation. It compensates through autonomic changes, vascular tone, hormonal pathways, fluid shifts, and redistribution of blood flow.

Therefore, if we wait for macro-vitals to clearly change, we may already be late.

A person can be dehydrated while blood pressure is still normal. A person can be under-recovered while heart rate is still acceptable. A person can be developing an infection before fever appears. A person can have poor microvascular function while resting vitals look normal. A person can feel “off” long before conventional vital signs cross a clinical threshold.

This is why macro-vitals are essential, but not enough. They are safety alarms. But they are not always the best language for early, personalized, continuous physiology.

3. Wearables gave us microvascular data, but we are forcing it back into macro-vitals

Most modern wearables are not only measuring the heart. They are measuring optical changes from blood volume dynamics in the skin. In simple terms, they are capturing signals from the microvascular layer.

PPG and rPPG signals contain information related to pulsatile blood flow, perfusion patterns, vascular tone, autonomic influence, pulse morphology, recovery kinetics, and physiological adaptation.

This is rich data. But instead of building a new physiological language from this data, we often compress it back into old measurements. Heart rate. SpO₂. Respiratory rate. Estimated blood pressure. Readiness score. Stress score. Sleep score.

These outputs are useful, but they may be only a small part of what the signal can offer.

We are sitting on a pile of golden microvascular data, but much of the industry is still trying to prove that microvascular physiology can be mapped back to macrovascular vitals.

That is a limited use of the technology. It is like using a smartphone only as a calculator. The sensor has evolved. The data has evolved. AI has evolved. The use case has evolved. But the interpretation layer is still catching up.

The future of wearables should not be only about recreating old vitals outside the hospital. The future should be about discovering new biomarkers that were not possible before continuous wearable sensing.

4. The missing problem is physiological interpretation

The challenge is not only hardware. It is not only sensor accuracy. It is not only signal quality. The deeper challenge is physiological interpretation.

We do not yet have a complete framework that connects microvascular signal patterns to real human biology across everyday states. This is why wearable data often becomes shallow. The user gets a score, but not a physiological explanation. Recovery is low. Stress is high. Sleep is poor. Readiness is reduced.

But why?

Is it hydration? Is it poor perfusion? Is it autonomic stress? Is it early infection? Is it overtraining? Is it inflammation? Is it gut-related metabolic load? Is it hormonal? Is it vascular ageing? Is it poor recovery after exercise?

This is the missing layer. We need to move from generic wearable scores to condition-linked microvascular biomarkers. Not just “your heart rate is 78.”

But:

What is your vascular response today? How is your perfusion pattern changing? How quickly are you recovering after stress? How does your body respond after hydration? How does your microvascular signal change during illness? How different are you from your own baseline?

The future is not raw data. The future is physiological state estimation.

5. Why now: AI and agents can connect the dots

This is why the timing matters. In the past, even if we collected rich microvascular data, we did not have the tools to fully interpret it.

Now AI changes the equation.

AI models can detect patterns across continuous time-series data. Agents can connect physiology with context. They can combine wearable signals with sleep, hydration, nutrition, exercise, symptoms, medication, stress, travel, temperature, environment, and baseline trends.

This creates a new opportunity. Instead of using microvascular data only to estimate heart rate, SpO₂, or blood pressure, we can use microvascular data to understand microvascular physiology directly.

This is the key shift. The future is not:

Microvascular data converted into macro-vitals.

The future is:

Microvascular data interpreted as microvascular physiology.

That means AI agents can move from generic health advice to personalized physiological guidance. Not just:

“You should drink more water.”

But:

“Your hydration-related vascular response appears slower than your baseline today. Consider a structured hydration intervention and reassess response.”

Not just:

“You are stressed.”

But:

“Your autonomic–vascular pattern is showing sustained stress load and poor recovery after sleep.”

Not just:

“You are not ready.”

But:

“Your recovery limitation today may be linked to hydration, sleep debt, and persistent vascular stress.”

This is where AI becomes useful in real health. Not because it can talk better. But because it can finally read a deeper physiological layer.

6. The opportunity: new biomarkers for the questions humans actually ask

The next generation of wearables should not only answer old clinical questions.

They should answer the real physiological questions humans ask every day.

How is my body hydrating right now?

Hydration is not only about how much water someone drinks.

It is also about effective circulating volume, vascular tone, perfusion response, recovery after fluid intake, and how the body distributes fluid under stress.

Urine colour, thirst, and body weight change are useful but limited. They are often late, subjective, or indirect. A microvascular hydration biomarker could help track hydration-related physiology in a more dynamic and personalized way.

Not just:

“Did I drink water?”

But:

“Is my body responding well to hydration?”

How are my organs perfusing right now?

Wearables cannot directly measure organ perfusion in the same way as advanced clinical tools.

But microvascular signals may provide a useful window into circulatory stress, peripheral perfusion, vascular tone, and compensation. This could become important for early deterioration, dehydration, infection, heat stress, recovery, and performance.

The goal is not to replace clinical perfusion assessment.

The goal is to create an earlier, continuous, home-based signal that tells us when the body is drifting away from its normal perfusion state.

What is the bottleneck for muscle growth?

Muscle growth is not only about training harder. It depends on recovery, sleep, nutrition, hydration, blood flow, inflammation, hormonal state, and autonomic balance. Today, many people train based on effort, soreness, and generic recovery scores.

But microvascular biomarkers may help us understand whether the body is actually ready to build.

Is the muscle growth bottleneck training load? Is it poor recovery? Is it low sleep quality? Is it hydration-related perfusion limitation? Is it inflammatory stress? Is it poor vascular response after exercise?

This could create a new generation of personalized performance biomarkers.

Am I under-recovered, and how can I fix it?

Recovery is one of the most important areas for wearables, but current recovery scores can be too generic.

A person may know recovery is low, but not know why. Microvascular vitals could help separate different recovery patterns.

Sleep-related recovery failure. Hydration-related recovery failure. Autonomic overload. Inflammatory stress. Post-exercise vascular fatigue. Early illness. Poor adaptation after travel or heat exposure.

This is where AI agents become powerful. Not just measuring recovery. But explaining the likely bottleneck and guiding the next intervention.

Is my gut health slowing down with age?

Gut health is complex. It cannot be reduced to one wearable signal. But gut physiology, metabolism, inflammation, autonomic regulation, vascular function, sleep, and ageing are deeply connected.

As people age, many describe feeling slower, heavier, more inflamed, less energetic, or less metabolically flexible.

Microvascular biomarkers may provide an indirect but useful window into how the body responds after meals, how inflammation affects vascular dynamics, how recovery changes with age, and how metabolic load appears in daily physiology.

This is still an early research area. But it is exactly the kind of question that continuous microvascular data and AI may help explore.

As a man, how does my sexual health function look?

Male sexual function is deeply vascular. It is also neurological, hormonal, psychological, metabolic, and relational. But vascular responsiveness is a major part of male sexual health.

Traditional vitals do not capture this well. A man can have normal resting blood pressure and heart rate but still have declining vascular responsiveness, poor recovery, stress-related erectile dysfunction, or early cardiometabolic dysfunction.

Microvascular vitals may help build a more objective, longitudinal picture of male vascular and sexual health.

Not as a replacement for clinical evaluation. But as an earlier, more personalized functional biomarker layer. This is important because sexual health is often one of the earliest areas where men notice changes in vascular performance.

Is my body stress due to early infection?

Before fever becomes obvious, before oxygen saturation drops, before blood pressure changes, the body may already show signs of physiological stress.

Autonomic changes, vascular tone shifts, altered perfusion, sleep disruption, increased resting heart rate, reduced recovery, and microvascular instability may appear before clear symptoms.

This does not mean wearables should diagnose infection alone. But microvascular vitals may help detect deviation from baseline earlier and trigger safer guidance.

Rest. Hydrate. Monitor symptoms. Repeat measurement. Escalate if risk increases. Seek clinical review if red flags appear.

This is where microvascular vitals can become an early warning and monitoring layer. Not a diagnostic engine. A physiological guidance layer.

7. What this is not

Microvascular vitals should not be positioned as magic. They should not be positioned as replacing doctors. They should not be positioned as diagnosing disease from one signal. They should not replace heart rate, blood pressure, oxygen saturation, temperature, laboratory tests, imaging, or clinical judgement.

This is not the argument.

The argument is that traditional vitals are not enough for the age of continuous monitoring and AI agents. Microvascular vitals should be developed as an additional layer. A baseline-personalized layer. A quality-gated layer. An uncertainty-aware layer. A condition-linked layer. A physiological state-estimation layer.

For safe deployment, these biomarkers must include signal quality checks, confidence levels, conservative escalation rules, clinical validation, and clear user communication. The goal is not to create false certainty. The goal is to create better physiological visibility.

Outlook

Wearables are not wrong.

Wearables may be one of the most important health technologies we have.

But we may be using them with the wrong mindset.

We are using continuous microvascular sensors to chase old macro-vitals.

Instead, we should use them to build a new physiological data layer.

A layer that helps answer real human questions:

How is my body hydrating? How is my body perfusing? Why am I under-recovered? What is limiting my performance? Is my body showing early stress? Is my vascular health changing with age? Is my sexual health reflecting deeper vascular decline? Is an infection building before I clearly feel sick?

These are not only wellness questions.

These are physiology questions.

And they may define the next generation of digital biomarkers.

The future of wearables is not only more data.

It is better physiology.

It is not only better heart rate, better SpO₂, or cuffless blood pressure.

It is a new layer of Microvascular Vitals: personalized, continuous, condition-linked biomarkers that help humans, clinicians, athletes, and AI agents understand the body earlier and more meaningfully.

This is the next layer. It is time to build it.